Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
san francisco blog main
new york blog main
new york top stories
san francisco top stories
biotech ipos
boston blog main
boston top stories
cancer drugs
deals
dihydroergotamine
europe blog main
fda
investing
medical device
nirogacestat
satsuma pharmaceuticals
springworks therapeutics
10x genomics
acute migrane
acute myeloid leukemia
alx oncology
autoimmune diseases
bain capital
bausch health
berkeley lights
black diamond therapeutics
bladder cancer
blueprint medicines
breast cancer
cancer
cancer immunotherapy
cd47
chronic kidney disease
deciphera pharmaceuticals
deerfield healthcare technology acquisitions
deerfield management company
What
biotech
4
×
companies
4
×
ipo
4
×
days
drug
hasn’t
ipos
leading
life
new
research
satsuma
science
slowed
springworks
street
wall
week
welcomed
activity
arrival
black
boost
cancer
clinic
diamond
dog
eluded
firm
followed
genomics
haul
hopes
industry
lead
led
line
lines
market
markets
Language
unset
Current search:
ipo
×
biotech
×
companies
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs